<DOC>
	<DOCNO>NCT02178488</DOCNO>
	<brief_summary>The purpose study treat persistent MRSA carrier vitamin D supplementation 12 month see number MRSA positive patient reduce .</brief_summary>
	<brief_title>Efficacy Study Vitamin D Supplementation Meticillin Resistant Staphylococcus Aureus ( MRSA ) Carriers</brief_title>
	<detailed_description />
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>1 . Persistent MRSAcarriers define 2 MRSApositive bacterial culture least one location , least 3 month apart 3 year prior inclusion . 2 . Men woman age â‰¥1875 3 . Signed 'informed consent ' 4 . Negative pregnancy test ( Uhcg ) accept use adequate anticonceptive method ( contraceptive , hormone/copperspiral ) . 1 . Should vitamin D supplementation least 6 month prior inclusion . 2 . Serum level 25hydroxy vitamin D3 &gt; 75 nmol/L 3 . Ongoing continuous antibiotic treatment . The patient antibiotic least 30 day prior inclusion 4 . Known sarcoidosis 5 . Primary secondary hyperparathyroidism 6 . Kidney failure define normal ageadjusted creatinin . 7 . Long term systemic treatment corticosteroid immunosuppressive medication 8 . Taking thiazides 9 . Hypercalcaemia ( verified laboratory result young 2 month ) 10 . Ongoing malignancy disorder 11 . If plan leave Stockholm county within 12 month inclusion 12 . History kidney stone 13 . Pregnancy ( ongoing plan ) 14 . Breastfeeding woman 15 . Taking part another clinical study involve drug 16 . Hypersensitivity cholecalciferol and/or excipients 17 . Other criterion could jeopardize study intention judge investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>